The study was co-led by a team of scientists at The Institute of Cancer Research, London, headed up by Dr Anguraj Sadanandam, and the University of Michigan in the US. This work, published in Nature today, was funded by Pancreatic Cancer UK, the Ian Harty Charitable Trust and the National Institutes of Health in the US.
Knowledge of CAM and open communication crucial when patients refuse conventional cancer treatment
When patients reject conventional cancer treatment and consider complementary and alternative medicine (CAM) instead, there is often a conflict between doctor and patient.